Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Prog. obstet. ginecol. (Ed. impr.) ; 56(2): 108-116, feb. 2013. tab, ilus
Article in Spanish | IBECS | ID: ibc-109181

ABSTRACT

La vulvovaginitis candidiásica recurrente (VVCR) es una entidad presente en la práctica diaria en las consultas y en urgencias. Sus síntomas causan molestias crónicas que repercuten seriamente en la calidad de vida de la mujer, empujándola a buscar constantemente una solución que no siempre llega. El diagnóstico debe confirmarse siempre mediante cultivo y el tratamiento debe basarse en el uso de antifúngicos imidazoles, tópicos u orales, con un tratamiento inicial con triple terapia para eliminar los síntomas e intentar eliminar los reservorios; seguida de un tratamiento de mantenimiento durante 6 a 12 meses. Las opciones para la prevención de la VVCR son muy limitadas y, exceptuando la eliminación del agente causal, ninguna otra medida preventiva ha resultado eficaz. Presentamos esta actualización de la VVCR en un intento de ayudar al profesional y colaborar en mejorar la atención de la mujer afecta de VVCR(AU)


Recurrent vulvovaginal candidiasis (RVVC) is a common infection in daily clinical and emergency practice. The symptoms of this infection cause distressing chronic conditions that seriously affect women's quality of life, prompting them to seek solutions that are sometimes hard to find. Diagnosis should always be confirmed by culture and treatment should be based on the use of topical or oral antifungal imidazoles. Triple therapy focused on symptom and reservoir elimination should initially be used, followed by maintenance therapy for 6 to 12 months. The options to prevent RVVC are highly limited and, except for elimination of the causative agent, no other preventive measures have been effective. We provide an updated review of RVVC in an attempt to aid health professionals and improve the care of women with this infection(AU)


Subject(s)
Humans , Female , Vulvovaginitis/complications , Vulvovaginitis/diagnosis , Vulvovaginitis/drug therapy , Candidiasis, Vulvovaginal/complications , Candidiasis, Vulvovaginal/diagnosis , Candidiasis, Vulvovaginal/drug therapy , Antifungal Agents/therapeutic use , Imidazoles/therapeutic use , Vulvovaginitis/physiopathology , Recurrence , Vulvovaginitis/epidemiology , Vulvovaginitis/etiology , Vaginal Diseases/etiology , Vaginal Diseases/microbiology , Vaginal Discharge/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...